Currently, Ventyx Biosciences Inc [VTYX] is trading at $4.68, up 25.13%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The VTYX shares have gain 10.38% over the last week, with a monthly amount drifted -10.69%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Ventyx Biosciences Inc [NASDAQ: VTYX] stock has seen the most recent analyst activity on March 12, 2024, when Wells Fargo upgraded its rating to a Overweight and also boosted its price target to $16 from $7. Previously, Oppenheimer upgraded its rating to Outperform on March 12, 2024, and kept the price target unchanged to $12. On November 07, 2023, downgrade downgraded it’s rating to Equal Weight and revised its price target to $8 on the stock. Stifel downgraded its rating to a Hold but stick to its price target of $6 on November 07, 2023. Oppenheimer downgraded its rating to a Perform. Morgan Stanley downgraded its rating to Equal-Weight for this stock on November 07, 2023, and downed its price target to $6. In a note dated November 07, 2023, H.C. Wainwright downgraded an Neutral rating on this stock.
This stock has fluctuated between a low of $1.87 and a high of $40.58 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $38.83 within the next 12 months. Ventyx Biosciences Inc [NASDAQ: VTYX] shares were valued at $4.68 at the most recent close of the market. An investor can expect a potential return of 729.7% based on the average VTYX price forecast.
Analyzing the VTYX fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.68, Equity is -1.28 and Total Capital is -0.81. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.05.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.95 points at the first support level, and at 3.22 for the second support level. However, for the 1st resistance point, the stock is sitting at 5.16, and for the 2nd resistance point, it is at 5.64.
Ventyx Biosciences Inc [VTYX] reported earnings per share of -$0.79 for its fiscal quarter that ended on 12/31/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.9/share, meaning a difference of $0.11 and a surprise factor of 12.20%. By comparison, the stated earnings for the previous quarter ended on 9/30/2023 were -$0.92 per share as compared to estimates of -$0.9 per share, a difference of -$0.02 representing a surprise of -2.20%.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Ventyx Biosciences Inc [NASDAQ:VTYX] is 11.87. Also, the Quick Ratio is 11.87, while the Cash Ratio stands at 2.32.
Transactions by insiders
Recent insider trading involved Mohan Raju, CEO AND PRESIDENT, that happened on Apr 02 ’24 when 4312.0 shares were sold. CHIEF BUSINESS OFFICER, Krueger Christopher W completed a deal on Apr 02 ’24 to sell 1651.0 shares. Meanwhile, CHIEF SCIENTIFIC OFFICER Nuss John sold 1651.0 shares on Apr 02 ’24.
